NEPH Insider Trading Activity and SEC Form 4 Filings
NEPH insider trading summary
No open-market insider purchases or sales of Nephros Inc (NEPH) have been reported on SEC Form 4 in the past 12 months.
Latest NEPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 30, 2024 | Arthur H Amron | Director | Buy | $7K (3,000 @ $2.24) |
| May 28, 2024 | Arthur H Amron | Director | Buy | $4K (2,000 @ $2.22) |
| May 16, 2024 | Robert R. Banks Jr. | President and CEO | Buy | $112K (50,000 @ $2.24) |
| Mar 12, 2024 | Arthur H Amron | Insider | Buy | $17K (7,000 @ $2.45) |
| Dec 7, 2023 | Robert R. Banks Jr. | President and CEO | Buy | $40K (18,000 @ $2.20) |
| Aug 15, 2023 | Robert R. Banks Jr. | President and CEO | Buy | $3K (1,901 @ $1.69) |
| Aug 14, 2023 | Robert R. Banks Jr. | President and CEO | Buy | $149 (99 @ $1.50) |
| Aug 20, 2021 | Wesley S. Lobo | Chief Marketing Officer | Buy | $8K (1,000 @ $7.92) |
| Aug 18, 2021 | Tom Gwydir | Director | Buy | $38K (5,000 @ $7.64) |
| Aug 18, 2021 | Andrew Astor | President & CEO | Buy | $19K (2,500 @ $7.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.